|
Market Closed -
Nasdaq
02:30:00 06/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.150 USD | -6.50% |
|
-5.74% | -61.02% |
| Market Cap | 1.09Cr 96.86L 88.6L 80.69L 1.52Cr 102.72Cr 1.56Cr 11Cr 4.26Cr 54Cr 4.08Cr 3.99Cr 171.67Cr | P/E 2026 * |
-0.47x | P/E 2027 * | -0.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.09Cr 96.86L 88.6L 80.69L 1.52Cr 102.72Cr 1.56Cr 11Cr 4.26Cr 54Cr 4.08Cr 3.99Cr 171.67Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 1.42x |
| Free-Float |
98.25% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CLRB | Delayed | |
CBOE
| CLRB | Real-time |
Last Transcript: Cellectar Biosciences, Inc.
| 1 day | -6.50% | ||
| 1 week | -5.74% | ||
| Current month | -4.56% | ||
| 1 month | -31.14% | ||
| 3 months | -54.37% | ||
| 6 months | -63.84% | ||
| Current year | -61.02% |
| 1 week | 1.11 |  | 1.37 |
| 1 month | 1.11 | | 1.62 |
| Current year | 1.11 | | 4.7 |
| 1 year | 1.11 | | 4.7 |
| 3 years | 1.11 | | 133.5 |
| 5 years | 1.11 | | 291 |
| 10 years | 1.11 | | 9,210.01 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Caruso
CEO | Chief Executive Officer | 67 | 15/06/2015 |
Chad Kolean
DFI | Director of Finance/CFO | 61 | 28/05/2014 |
Jarrod Longcor
COO | Chief Operating Officer | 53 | 23/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
John Neis
BRD | Director/Board Member | 57 | 01/02/2008 |
James Caruso
BRD | Director/Board Member | 67 | 15/06/2015 |
Douglas Swirsky
CHM | Chairman | 56 | 01/08/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/07/26 | Free | Director | 15,000 | 0.5603% | ||
| 08/07/26 | Free | Director | 15,000 | 0.5603% | ||
| 07/07/26 | Free | Director | 25,000 | 0.9339% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.50% | -5.74% | -65.57% | -98.55% | 1.09Cr | |
| -3.76% | -0.65% | +47.41% | +140.35% | 1,21600Cr | |
| -1.45% | -1.05% | +46.41% | +79.94% | 66TCr | |
| -2.24% | -0.88% | +32.97% | +103.82% | 51TCr | |
| -2.43% | -5.06% | +44.42% | +61.50% | 38TCr | |
| -2.27% | +0.42% | +74.12% | +42.14% | 36TCr | |
| -2.35% | -2.06% | +28.55% | +55.53% | 31TCr | |
| -3.48% | -2.98% | +5.53% | +31.80% | 29TCr | |
| -3.80% | -0.10% | +43.90% | +70.56% | 25TCr | |
| -3.96% | +1.18% | +36.70% | +105.38% | 21TCr | |
| Average | -2.37% | -0.03% | +29.44% | +59.25% | 41.88TCr | |
| Weighted average by Cap. | -1.53% | +0.03% | +42.46% | +90.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 76.49L 68.16L 62.34L 56.78L 1.07Cr 72Cr 1.1Cr 7.49Cr 2.99Cr 38Cr 2.87Cr 2.81Cr 120.79Cr |
| Net income | -3.16Cr -2.82Cr -2.58Cr -2.35Cr -4.43Cr -298.92Cr -4.55Cr -31Cr -12Cr -158.31Cr -12Cr -12Cr -499.55Cr | -3.74Cr -3.33Cr -3.05Cr -2.77Cr -5.23Cr -353.21Cr -5.37Cr -37Cr -15Cr -187.06Cr -14Cr -14Cr -590.27Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | $1.150 | -6.50% | 1,44,194 |
| 04/26/04 | $1.230 | -6.11% | 87,794 |
| 03/26/03 | $1.310 | +7.38% | 1,40,914 |
| 02/26/02 | $1.220 | +1.24% | 66,545 |
| 30/26/30 | $1.205 | -1.23% | 55,287 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CLRB Stock
Select your edition
All financial news and data tailored to specific country editions
